Navigation Links
Abiraterone Acetate Significantly Improved Overall Survival for Patients with Metastatic Advanced Prostate Cancer
Date:10/11/2010

n cancer overall, is a significant public health problem," said Howard I. Scher, MD, Memorial Sloan-Kettering Cancer Center, one of the lead COU-AA-301 investigators.  "These results are important because men with progressive metastatic, castration-resistant prostate cancer often have a poor prognosis and currently have few treatment options."  

A program that provides early access to abiraterone acetate for eligible patients is expected to be opened in the U.S. in October and will be opened in sites outside the U.S. in the following months, with the timing of the program contingent on local health authority and ethics committee approvals.  

"The results of this abiraterone acetate Phase 3 study in patients with metastatic advanced prostate cancer bring us closer to achieving our goal of developing extraordinary preventive, diagnostic and therapeutic solutions based on our tumor microenvironment strategy," said William N. Hait, MD, PhD, Global Therapeutic Head, Oncology, Ortho Biotech Oncology Research & Development.  "We believe that abiraterone acetate is an important medical advance, and we look forward to further developing oncology therapeutic options that may impact patients' lives."  

Ortho Biotech Oncology Research & Development, a unit of Cougar Biotechnology, Inc., previously announced that the Independent Data Monitoring Committee recommended unblinding this Phase 3 study after a pre-specified interim analysis demonstrated a statistically significant improvement in median overall survival and an acceptable safety profile.  The IDMC also recommended that patients in the prednisone/prednisolone plus placebo group be offered treatment with abiraterone acetate.

Study Design

This randomized, double-blind placebo-controlled Phase 3 study was conducted in 147 centers in 13 countries.  Patients with metastatic advanced prostate cancer previously treated with docetaxel (N=1,195) w
'/>"/>

SOURCE Ortho Biotech Oncology Research & Development
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnsons Abiraterone Compared With Other Emerging Therapies in Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
2. Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
3. Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
4. Roxane Laboratories, Inc. Updated Launch of Calcium Acetate Capsules, 667mg
5. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
6. Alba Therapeutics Corporation Announces the Next Clinical Trial of Its Lead Compound, Larazotide Acetate and Promotions
7. FDA Advisory Committee Unanimously Recommends Approval of HRA Pharmas Ulipristal Acetate for Emergency Contraception
8. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
9. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
10. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
11. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... , Oct. 31, 2014  Lycera Corp., a ... treat autoimmune disease and cancer, today announced that ... RORgamma agonist product candidates will be presented at ... of Cancer (SITC) being held November 6-9, 2014 ... National Harbor, MD.  The poster, entitled " Novel ...
(Date:10/31/2014)... 31, 2014 Investor-Edge has initiated ... NSPH ), Isis Pharmaceuticals Inc. (NASDAQ: ... ), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ), ... these five companies can be accessed at: http://investor-edge.com/register ... NASDAQ Composite ended at 4,566.14, up 0.37%, the Dow ...
(Date:10/31/2014)... 31, 2014 ThynkWare ( www.thynkware.com ) is ... text and email messages using their thoughts. ... by ThynkWare,s founder, Duane Cash , which is ... This technology allows users to control their devices in ... thought. ThynkWare provides the interface layer between ...
Breaking Medicine Technology:Lycera Announces Presentation of Data on Anti-Tumor Activity of Novel Synthetic RORgamma Agonists at Society for Immunotherapy of Cancer Meeting 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices 2
... TAMPA, Fla., May 31, 2011 Following through with plans ... has started services in Florida. Currently operating on a fee ... insurance company contracting in the state. IMD Companies anticipates that ... within a short period of time. ABOUT IMD ...
... 2011 HeartSine Technologies, Inc, a world leader ... warranty period to an exclusive 10 years on its popular ... Defibrillator (PAD) for the treatment of ... the fastest growing AED. The life of its Pad-Pak ® ...
Cached Medicine Technology:IMD Companies, Inc. Announces OMI Operations in Florida 2HeartSine® Increases AED System Warranty to Longest in the Industry 2
(Date:10/31/2014)... first study of its kind, Rice University researchers have ... cause cancer cells to become metastatic. The research reveals ... cells to both migrate and form new tumors. Researchers ... drugs that interfere with the genetic switches that cancer ... circulating tumor cells -- two of the main players ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 Monica ... physician, knows all too well the chaos that can ... the end-of-life. “The vast majority of Americans who come ... own lives are completely unprepared for the moment and ... ListStuffFast app can serve as a catalyst for a ...
(Date:10/31/2014)... 31, 2014 Energy Textiles has recently ... new gear is now available online, and Energy Textile ... of Celliant infrared-active athletic gear over compression gear. , ... contract has been signed for Under Armour to provide ... next eight years. In light of this decision, Energy ...
(Date:10/31/2014)... research suggests that insomnia is a major contributor to ... fatal injuries. The results underscore the importance of the ... Sleep Awareness Project. , Results show that the risk ... with the number of insomnia symptoms present. People with ... likely to die from a fatal injury than those ...
(Date:10/31/2014)... York (PRWEB) October 31, 2014 North ... Eye in Garden City, Long Island and the addition ... their medical staff, according to North Shore Eye Care ... the Emeritus Acting Chairman of the Department of Ophthalmology ... successful practice in Garden City for more than 30 ...
Breaking Medicine News(10 mins):Health News:Decoding the emergence of metastatic cancer stem cells 2Health News:Decoding the emergence of metastatic cancer stem cells 3Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 3Health News:Compression Gear--Is There a Better Alternative? 2Health News:Compression Gear--Is There a Better Alternative? 3Health News:Compression Gear--Is There a Better Alternative? 4Health News:Insomnia increases risk of motor vehicle deaths, other fatal injuries 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 3
... has identified factors that predict the ability of a ... arthroscopy surgery. The study by Hospital for Special Surgery ... Orthopaedic Surgeons annual meeting, held Feb. 15-19 in San ... that ballet dancers were significantly less likely to be ...
... is associated with negative outcomes for the mother, including increased ... length of stay in the hospital, and does not provide ... deliveries continues to climb, it is important for physicians and ... The new findings, published in the February issue of ...
... diabetes and CKD have an increased risk of adverse ... diabetes and overt nephropathy develop End-Stage Renal Disease (ESRD) ... of death and ESRD may confound the estimates of ... at the University of Helsinki, University Hospital of Helsinki ...
... Behen HealthDay Reporter , THURSDAY, Feb. 17 (HealthDay ... remembering, learning and processing information in warm weather than in ... Kessler Foundation in West Orange, N.J., found that patients with ... or cognitive functioning, on cooler days than they did at ...
... , THURSDAY, Feb. 17 (HealthDay News) -- People who ... times increased risk of developing Parkinson,s disease, a new ... Parkinson,s disease and 358 people without the nervous system ... Farming and Movement Evaluation Study involving licensed pesticide applicators ...
... WASHINGTON "Go Viral to Improve Health: IOM-NAE Health ... of Medicine and National Academy of Engineering to promote ... to spur interest in harnessing new technologies and data ... on university and college students studying engineering, computer science, ...
Cached Medicine News:Health News:Study explores ability of professional dancers to return to their career after hip arthroscopy 2Health News:Study explores ability of professional dancers to return to their career after hip arthroscopy 3Health News:Scheduled deliveries raise risks for mothers, do not benefit newborns 2Health News:Scheduled deliveries raise risks for mothers, do not benefit newborns 3Health News:Competing risks analysis highlights new targets in preventing ESRD and death of diabetics 2Health News:Warm Weather May Cloud Thinking in MS Patients 2Health News:Warm Weather May Cloud Thinking in MS Patients 3Health News:2 Pesticides Linked to Parkinson's in Study 2Health News:IOM and NAE launch collegiate challenge aimed at solving health problems 2
DCR Set, Angled....
... The Leica CM3050 S Cryostat ... with excellent safety standards for ... applications. The Leica CM3050 S ... for all cryosectioning research applications ...
... The Bright 7500 is a freestanding ... liquid decontamination system and a radial ... to cut a wide range of ... effective for use in high biohazard ...
... - a vision becomes reality. Numerous ... the users many benefits.,The Cryo-Star is ... retraction that incorporates a unique refrigeration ... cooling. This facilitates applications in both ...
Medicine Products: